1
|
Wang K, Han L, Mustakis J, Li B, Magano J, Damon DB, Dion A, Maloney MT, Post R, Li R. Kinetic and Data-Driven Reaction Analysis for Pharmaceutical Process Development. Ind Eng Chem Res 2019. [DOI: 10.1021/acs.iecr.9b03578] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Ke Wang
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Lu Han
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Jason Mustakis
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Bryan Li
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Javier Magano
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - David B. Damon
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Amelie Dion
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Mark T. Maloney
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Ronald Post
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Ruizhi Li
- Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
2
|
Escudero CA, Cabeza C, Moya-Alvarado G, Maloney MT, Flores CM, Wu C, Court FA, Mobley WC, Bronfman FC. c-Jun N-terminal kinase (JNK)-dependent internalization and Rab5-dependent endocytic sorting mediate long-distance retrograde neuronal death induced by axonal BDNF-p75 signaling. Sci Rep 2019; 9:6070. [PMID: 30988348 PMCID: PMC6465280 DOI: 10.1038/s41598-019-42420-6] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2018] [Accepted: 03/25/2019] [Indexed: 02/01/2023] Open
Abstract
During the development of the sympathetic nervous system, signals from tropomyosin-related kinase receptors (Trks) and p75 neurotrophin receptors (p75) compete to regulate survival and connectivity. During this process, nerve growth factor (NGF)- TrkA signaling in axons communicates NGF-mediated trophic responses in signaling endosomes. Whether axonal p75 signaling contributes to neuronal death and how signaling endosomes contribute to p75 signaling has not been established. Using compartmentalized sympathetic neuronal cultures (CSCGs) as a model, we observed that the addition of BDNF to axons increased the transport of p75 and induced death of sympathetic neurons in a dynein-dependent manner. In cell bodies, internalization of p75 required the activity of JNK, a downstream kinase mediating p75 death signaling in neurons. Additionally, the activity of Rab5, the key GTPase regulating early endosomes, was required for p75 death signaling. In axons, JNK and Rab5 were required for retrograde transport and death signaling mediated by axonal BDNF-p75 in CSCGs. JNK was also required for the proper axonal transport of p75-positive endosomes. Thus, our findings provide evidence that the activation of JNK by p75 in cell bodies and axons is required for internalization to a Rab5-positive signaling endosome and the further propagation of p75-dependent neuronal death signals.
Collapse
Affiliation(s)
- C A Escudero
- Center for Aging and Regeneration (CARE UC) and Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - C Cabeza
- Center for Aging and Regeneration (CARE UC) and Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.,Center of Cellular and Integrative Physiology, Faculty of Medicine, Clínica Alemana, Universidad del Desarrollo, Santiago, Chile
| | - G Moya-Alvarado
- Center for Aging and Regeneration (CARE UC) and Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - M T Maloney
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
| | - C M Flores
- Center for Aging and Regeneration (CARE UC) and Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - C Wu
- Department of Neurosciences, University of California, San Diego, La Jolla, California, 92093, USA
| | - F A Court
- Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile and FONDAP Center for Geroscience, Brain Health and Metabolism, Santiago, Chile
| | - W C Mobley
- Department of Neurosciences, University of California, San Diego, La Jolla, California, 92093, USA
| | - F C Bronfman
- Center for Aging and Regeneration (CARE UC) and Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
| |
Collapse
|
3
|
Sieser JE, Maloney MT, Chisowa E, Brenek SJ, Monfette S, Salisbury JJ, Do NM, Singer RA. Ir-Catalyzed Borylation as an Efficient Route to a Nicotine Hapten. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00053] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Janice E. Sieser
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Mark T. Maloney
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Esmort Chisowa
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Steven J. Brenek
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Sebastien Monfette
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - John J. Salisbury
- Analytical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Nga M. Do
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Robert A. Singer
- Chemical Research and Development, Pfizer Worldwide Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
4
|
Maloney MT, Jones BP, Olivier MA, Magano J, Wang K, Ide ND, Palm AS, Bill DR, Leeman KR, Sutherland K, Draper J, Daly AM, Keane J, Lynch D, O’Brien M, Tuohy J. Palbociclib Commercial Manufacturing Process Development. Part II: Regioselective Heck Coupling with Polymorph Control for Processability. Org Process Res Dev 2016. [DOI: 10.1021/acs.oprd.6b00069] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Mark T. Maloney
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Brian P. Jones
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Mark A. Olivier
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Javier Magano
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Ke Wang
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Nathan D. Ide
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Andrew S. Palm
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - David R. Bill
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Kyle R. Leeman
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - Karen Sutherland
- Pharmaceutical
Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States
| | - John Draper
- Pfizer Global R&D, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
| | | | - Joseph Keane
- Pfizer Global Supply, Ringaskiddy, Co. Cork, Ireland
| | - Denis Lynch
- Pfizer Global Supply, Ringaskiddy, Co. Cork, Ireland
| | - Marie O’Brien
- Pfizer Global Supply, Ringaskiddy, Co. Cork, Ireland
| | - Joanne Tuohy
- Pfizer Global Supply, Ringaskiddy, Co. Cork, Ireland
| |
Collapse
|
5
|
Lamberto DJ, Maloney MT, Murugesan S, Ramakrishnan S. Special Feature Section: Engineering Contributions to Process Chemistry. Org Process Res Dev 2015. [DOI: 10.1021/acs.oprd.5b00254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- David J. Lamberto
- Chemical Process Development and Commercialization, Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
| | - Mark T. Maloney
- Chemical Research and Development, Pfizer Inc., Eastern
Point Road, Groton, Connecticut 06340, United States
| | - Saravanababu Murugesan
- Medication
and Procedural
Solutions, BD Medical, Becton Dickinson Co., 1 Becton Drive, Franklin Lakes, New Jersey 07417, United States
| | - Srividya Ramakrishnan
- Integrated Product
Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad 500090, India
| |
Collapse
|
6
|
Magano J, Bock B, Brennan J, Farrand D, Lovdahl M, Maloney MT, Nadkarni D, Oliver WK, Pozzo MJ, Teixeira JJ, Wang J, Rizzo J, Tumelty D. Chromatography- and Lyophilization-Free Synthesis of a Peptide-Linker Conjugate. Org Process Res Dev 2014. [DOI: 10.1021/op4002998] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Javier Magano
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Brandon Bock
- Analytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - John Brennan
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Douglas Farrand
- Analytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Michael Lovdahl
- Analytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Mark T. Maloney
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Durgesh Nadkarni
- Biotherapeutics Pharmaceutical Sciences, Pfizer Worldwide Research & Development, 401 North Middletown Road, Pearl River, New York 10965, United States
| | - Wendy K. Oliver
- Analytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Mark J. Pozzo
- Biotherapeutics Pharmaceutical Sciences, Pfizer Worldwide Research & Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017, United States
| | - John J. Teixeira
- Chemical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Jian Wang
- Analytical Research & Development, Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - John Rizzo
- CovX Research, 9381 Judicial
Drive, San Diego, California 92121, United States
| | - David Tumelty
- CovX Research, 9381 Judicial
Drive, San Diego, California 92121, United States
| |
Collapse
|
7
|
Lamberto DJ, Maloney MT, Murugesan S. Special Feature Section: Engineering Contributions to Chemical Process Development. Org Process Res Dev 2013. [DOI: 10.1021/op400248x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- David J. Lamberto
- Chemical Process Development and Commercialization, Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States
| | - Mark T. Maloney
- Chemical Research and Development, Pfizer Inc., Eastern
Point Road, Groton, Connecticut 06340, United States
| | - Saravanababu Murugesan
- Late Phase
Chemical Development, Research and Development, Bristol-Myers Squibb Co., One Squibb Drive, New Brunswick, New Jersey 08903, United States
| |
Collapse
|
8
|
am Ende D, Birch M, Brenek SJ, Maloney MT. Development and Application of Laboratory Tools To Predict Particle Properties upon Scale-Up in Agitated Filter-Dryers. Org Process Res Dev 2013. [DOI: 10.1021/op400080x] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- David am Ende
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Melissa Birch
- Pharmaceutical
Sciences, Pfizer Inc., Ramsgate Road, Sandwich,
Kent CT13 9NJ,
U.K
| | - Steven J. Brenek
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Mark T. Maloney
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| |
Collapse
|
9
|
Hawkins JM, Dubé P, Maloney MT, Wei L, Ewing M, Chesnut SM, Denette JR, Lillie BM, Vaidyanathan R. Synthesis of an H3 Antagonist via Sequential One-Pot Additions of a Magnesium Ate Complex and an Amine to a 1,4-Ketoester followed by Carbonyl-Directed Fluoride Addition. Org Process Res Dev 2012. [DOI: 10.1021/op300093j] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Joel M. Hawkins
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Pascal Dubé
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Mark T. Maloney
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Lulin Wei
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Marcus Ewing
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Stephen M. Chesnut
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Joshua R. Denette
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Brett M. Lillie
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| | - Rajappa Vaidyanathan
- Pharmaceutical Sciences, Pfizer Inc., Eastern Point Road, Groton, Connecticut
06340, United States
| |
Collapse
|
10
|
Bamburg JR, Bernstein BW, Davis RC, Flynn KC, Goldsbury C, Jensen JR, Maloney MT, Marsden IT, Minamide LS, Pak CW, Shaw AE, Whiteman I, Wiggan O. ADF/Cofilin-actin rods in neurodegenerative diseases. Curr Alzheimer Res 2010; 7:241-50. [PMID: 20088812 PMCID: PMC4458070 DOI: 10.2174/156720510791050902] [Citation(s) in RCA: 127] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2009] [Accepted: 11/24/2009] [Indexed: 11/22/2022]
Abstract
Dephosphorylation (activation) of cofilin, an actin binding protein, is stimulated by initiators of neuronal dysfunction and degeneration including oxidative stress, excitotoxic glutamate, ischemia, and soluble forms of beta-amyloid peptide (Abeta). Hyperactive cofilin forms rod-shaped cofilin-saturated actin filament bundles (rods). Other proteins are recruited to rods but are not necessary for rod formation. Neuronal cytoplasmic rods accumulate within neurites where they disrupt synaptic function and are a likely cause of synaptic loss without neuronal loss, as occurs early in dementias. Different rod-inducing stimuli target distinct neuronal populations within the hippocampus. Rods form rapidly, often in tandem arrays, in response to stress. They accumulate phosphorylated tau that immunostains for epitopes present in "striated neuropil threads," characteristic of tau pathology in Alzheimer disease (AD) brain. Thus, rods might aid in further tau modifications or assembly into paired helical filaments, the major component of neurofibrillary tangles (NFTs). Rods can occlude neurites and block vesicle transport. Some rod-inducing treatments cause an increase in secreted Abeta. Thus rods may mediate the loss of synapses, production of excess Abeta, and formation of NFTs, all of the pathological hallmarks of AD. Cofilin-actin rods also form within the nucleus of heat-shocked neurons and are cleared from cells expressing wild type huntingtin protein but not in cells expressing mutant or silenced huntingtin, suggesting a role for nuclear rods in Huntington disease (HD). As an early event in the neurodegenerative cascade, rod formation is an ideal target for therapeutic intervention that might be useful in treatment of many different neurological diseases.
Collapse
Affiliation(s)
- J R Bamburg
- Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, 80523, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Dorow RL, Herrinton PM, Hohler RA, Maloney MT, Mauragis MA, McGhee WE, Moeslein JA, Strohbach JW, Veley MF. Development of an Efficient Synthesis of the Pyrrolquinolone PHA-529311. Org Process Res Dev 2006. [DOI: 10.1021/op050251y] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- R. L. Dorow
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Paul M. Herrinton
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Richard A. Hohler
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Mark T. Maloney
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Michael A. Mauragis
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - William E. McGhee
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Jeffery A. Moeslein
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Joseph W. Strohbach
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| | - Michael F. Veley
- Chemical Research and Development, Pfizer Global Research and Development, Pfizer Incorporated, 7000 Portage Road, Kalamazoo Michigan 49001, U.S.A
| |
Collapse
|
12
|
Lu CV, Chen JJ, Perrault WR, Conway BG, Maloney MT, Wang Y. Development of a Pilot-Scale Preparation of N-[[(5S)-3-[4-(1,1-Dioxido-4- thiomorpholinyl)-3,5-difluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, PNU-288034, an Oxazolidinone Antibacterial Agent. Org Process Res Dev 2006. [DOI: 10.1021/op050207i] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Cuong V. Lu
- Chemical Process Research and Development, Pfizer, Kalamazoo, Michigan 49001, U.S.A
| | - Jiong J. Chen
- Chemical Process Research and Development, Pfizer, Kalamazoo, Michigan 49001, U.S.A
| | - William R. Perrault
- Chemical Process Research and Development, Pfizer, Kalamazoo, Michigan 49001, U.S.A
| | - Brian G. Conway
- Chemical Process Research and Development, Pfizer, Kalamazoo, Michigan 49001, U.S.A
| | - Mark T. Maloney
- Chemical Process Research and Development, Pfizer, Kalamazoo, Michigan 49001, U.S.A
| | - Ying Wang
- Chemical Process Research and Development, Pfizer, Kalamazoo, Michigan 49001, U.S.A
| |
Collapse
|
13
|
Minamide LS, Shaw AE, Sarmiere PD, Wiggan O, Maloney MT, Bernstein BW, Sneider JM, Gonzalez JA, Bamburg JR. Production and use of replication-deficient adenovirus for transgene expression in neurons. Methods Cell Biol 2004; 71:387-416. [PMID: 12884701 DOI: 10.1016/s0091-679x(03)01019-7] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Adenoviruses infect a wide range of cell types, do not require integration into the host cell genome, and can be produced as replication-deficient viruses capable of expressing transgenes behind any desired promoter. Thus, they are ideal for use in expressing transgenes in the postmitotic neuron. This chapter describes simplifications in the protocols for making recombinant adenoviruses and their use in expressing transgenes in primary neurons of several different types.
Collapse
Affiliation(s)
- L S Minamide
- Department of Biochemistry and Molecular Biology, Program in Molecular, Cellular and Integrative Neuroscience, Colorado State University, Fort Collins, Colorado 80523, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Perrault WR, Pearlman BA, Godrej DB, Jeganathan A, Yamagata K, Chen JJ, Lu CV, Herrinton PM, Gadwood RC, Chan L, Lyster MA, Maloney MT, Moeslein JA, Greene ML, Barbachyn MR. The Synthesis of N-Aryl-5(S)-aminomethyl-2-oxazolidinone Antibacterials and Derivatives in One Step from Aryl Carbamates. Org Process Res Dev 2003. [DOI: 10.1021/op034028h] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- William R. Perrault
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Bruce A. Pearlman
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Delara B. Godrej
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Azhwarsamy Jeganathan
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Koji Yamagata
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Jiong J. Chen
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Cuong V. Lu
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Paul M. Herrinton
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Robert C. Gadwood
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Lai Chan
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Mark A. Lyster
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Mark T. Maloney
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Jeffery A. Moeslein
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Meredith L. Greene
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Michael R. Barbachyn
- Early Chemical Process Research and Development, Chemical Process Research and Development, and Medicinal Chemistry Research, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| |
Collapse
|
15
|
Lipton MF, Mauragis MA, Maloney MT, Veley MF, VanderBor DW, Newby JJ, Appell RB, Daugs ED. The Synthesis of OSU 6162: Efficient, Large-Scale Implementation of a Suzuki Coupling. Org Process Res Dev 2003. [DOI: 10.1021/op025620u] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael F. Lipton
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - Michael A. Mauragis
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - Mark T. Maloney
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - Michael F. Veley
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - Dale W. VanderBor
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - John J. Newby
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - Robert B. Appell
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| | - Edward D. Daugs
- Early Process Research and Development, Pharmacia Corporation, 7000 Portage Road, Kalamazoo, Michigan 49001, U.S.A., and Dow Pharmaceutical Services, The Dow Chemical Co., Midland, Michigan 48674, U.S.A
| |
Collapse
|
16
|
Carpenter DE, Imbordino RJ, Maloney MT, Moeslein JA, Reeder MR, Scott A. Process Development and Scale-Up of the Potential Thiazolidinedione Antidiabetic Candidate PNU-91325. Org Process Res Dev 2002. [DOI: 10.1021/op025549s] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Donald E. Carpenter
- Early Process Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Rick J. Imbordino
- Early Process Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Mark T. Maloney
- Early Process Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Jeffery A. Moeslein
- Early Process Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Michael R. Reeder
- Early Process Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| | - Allen Scott
- Early Process Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49001, U.S.A
| |
Collapse
|
17
|
Maloney MT, Chapman TW, Baker AJ. An Engineering Analysis of the Production of Xylose by Dilute Acid Hydrolysis of Hardwood Hemicellulose. Biotechnol Prog 1986; 2:192-202. [DOI: 10.1002/btpr.5420020407] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
18
|
Maloney MT, Chapman TW, Baker AJ. Dilute acid hydrolysis of paper birch: Kinetics studies of xylan and acetyl-group hydrolysis. Biotechnol Bioeng 1985; 27:355-61. [DOI: 10.1002/bit.260270321] [Citation(s) in RCA: 135] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
19
|
|